Ahlcon Parenterals (India) Profile
Key Indicators
- Authorised Capital ₹ 200.00 Cr
- Paid Up Capital ₹ 116.92 Cr
- Company Age 33 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 162.56 Cr
- Revenue Growth -23.87%
- Profit Growth -201.72%
- Ebitda -86.55%
- Net Worth -95.75%
- Total Assets -11.61%
About Ahlcon Parenterals (India)
Ahlcon Parenterals (India) Limited (APIL) is a leading Public Limited Indian Non-Government Company incorporated in India on 20 January 1992 and has a history of 33 years and one month. Its registered office is in Delhi, India.
The Corporate was formerly known as Gujarat Inject (Rajasthan) Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 200.00 Cr and a paid-up capital of Rs 116.92 Cr.
The company has closed loans amounting to ₹162.56 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Ahlcon Parenterals (India) Limited India are Ranjan Sahu as COMPANY SECRETARY and Rajesh Garg as Cfo. Aditya Banerjee, Vinod Bajaj, Rajiv Mathur, and Two other members serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24239DL1992PLC047245
- Company No.
047245
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
20 Jan 1992
- Date of AGM
13 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Ahlcon Parenterals (India)?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Aditya Banerjee ![]() | Managing Director | 01-Oct-2022 | Current |
Ranjan Sahu | Company Secretary | 01-Dec-2007 | Current |
Rajesh Garg | CFO | 10-Sep-2024 | Current |
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vinod Bajaj ![]() | Director | 21-Jun-2024 | Current |
Rajiv Mathur ![]() | Director | 21-Jun-2024 | Current |
Eva Maegerlein ![]() | Director | 31-Oct-2022 | Current |
Navin Hans ![]() | Whole-Time Director | 28-Apr-2023 | Current |
Financial Performance of Ahlcon Parenterals (India).
Ahlcon Parenterals (India) Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 23.87% decrease. The company also saw a substantial fall in profitability, with a 201.72% decrease in profit. The company's net worth observed a substantial decline by a decrease of 95.75%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Ahlcon Parenterals (India)?
In 2021, Ahlcon Parenterals (India) had a promoter holding of 96.12% and a public holding of 3.89%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹0
₹162.56 Cr
Charges Breakdown by Lending Institutions
- Syndicate Bank : 74.00 Cr
- Punjab & Sind Bank : 73.96 Cr
- Allahabad Bank : 10.00 Cr
- The Allahabad Bank : 4.60 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
25 Mar 2010 | Punjab & Sind Bank | ₹4.00 Cr | Satisfied |
25 Mar 2010 | Punjab & Sind Bank | ₹21.11 Cr | Satisfied |
25 Mar 2010 | Punjab & Sind Bank | ₹13.00 Cr | Satisfied |
25 Mar 2010 | Punjab & Sind Bank | ₹35.85 Cr | Satisfied |
22 Oct 2005 | Syndicate Bank | ₹37.00 Cr | Satisfied |
How Many Employees Work at Ahlcon Parenterals (India)?
Ahlcon Parenterals (India) has a workforce of 476 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Ahlcon Parenterals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ahlcon Parenterals (India)'s trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.